Sign up to save your podcasts
Or
Share 25: Weekly Dose: New Endocrine Guidelines, Digital Asthma Gains, AI Trust Gap, GLP-1 & Dementia Risk, First CHE Treatment
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
25: Weekly Dose: New Endocrine Guidelines, Digital Asthma Gains, AI Trust Gap, GLP-1 & Dementia Risk, First CHE Treatment
This week’s Weekly Dose covers new Endocrine Society guidelines on preexisting diabetes in pregnancy and primary aldosteronism screening, a digital asthma management tool that improved symptoms but revealed disparities, public perceptions of physicians using AI, evidence linking GLP-1 receptor agonists to reduced dementia risk, and the FDA’s first approved treatment for chronic hand eczema.
View all episodes
By Medical Economics PulseThis week’s Weekly Dose covers new Endocrine Society guidelines on preexisting diabetes in pregnancy and primary aldosteronism screening, a digital asthma management tool that improved symptoms but revealed disparities, public perceptions of physicians using AI, evidence linking GLP-1 receptor agonists to reduced dementia risk, and the FDA’s first approved treatment for chronic hand eczema.